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Between 1991-1996, 8 patients experienced rare life-threatening reactions that followed 
the transfusion of blood infected with Yersinia enterocolitica. The first reported case 
occurred in 1991 and was followed by seven others that direct! y caused or contributed to 
the death of 5 of 8 patients. Y. enterocolitica is a food and water borne infection of the 
gastrointestinal tract which in adults is often asymptomatic. An unknown number of those 
infected experience a period of self-limiting bacteraemia. The large volume of blood 
collected during donation phlebotomy may contain small numbers of bacteria that can 
increase in number during blood bank storage, producing potentially lethal levels of 
bacteria and toxin. Currently there are no reliable methods available to distinguish blood 
donations that present the greatest risk from those that present little risk. 
This thesis, reports on the evaluation of two techniques to prevent the transfusion of blood 
infected with Y. enterocolitica. The first, a molecular method, was used to amplify 
bacterial DNA in blood by Polymerase Chain Reaction (PCR). A 425 bp product was 
amplified from DNA extractions of infected blood. Results showed that the technical 
complexities of the methodology, together with poor sensitivity and the need for large-
scale donation sampling make PCR as applied for this purpose unattractive. 
An Enzyme Linked lmmunosorbent Assay was developed to detect current/recent infection 
with Y. enterocolitica in healthy blood donors. Polystyrene beads were coated with 
bacterial proteins to detect IgA antibody to Y. enterocolitica in human serum. The sera 
from donors of confirmed unit infections, paired sera from culture-proven Y. enterocolitica 
gastrointestinal tract infection and sera from volunteer blood donors were tested. Results 
showed that the sera of six bacteraemic blood donors tested contained elevated levels of 
IgA antibody. High rates of positivity (26/27), were detected in sera from culture-
confirmed GIT infection and a rate of 4.04% seropositivity was found among 495 blood 
donors enrolled in a clinical trial. Results showed a strong correlation between IgA 
seropositivity, and recipient risk associated with the transfusion of blood heavily infected 
with Y. enterocolitica. The work demonstrated how the use of a simple screening test for 
recent infection, could be used to exclude high risk donations and improve the safety of 
blood transfusion in New Zealand. 
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